Diffusion-weighted endorectal MR imaging at 3 T for prostate cancer: tumor detection and assessment of aggressiveness.
暂无分享,去创建一个
Yousef Mazaheri | Oguz Akin | Tobias Franiel | Hedvig Hricak | Hebert Alberto Vargas | H. Hricak | J. Eastham | O. Akin | H. Vargas | Y. Mazaheri | C. Moskowitz | Junting Zheng | T. Franiel | Kazuma Udo | Junting Zheng | James Eastham | Chaya Moskowitz | Kazuma Udo
[1] A. Jemal,et al. Cancer Statistics, 2010 , 2010, CA: a cancer journal for clinicians.
[2] Gary P Liney,et al. Correlation of ADC and T2 Measurements With Cell Density in Prostate Cancer at 3.0 Tesla , 2009, Investigative radiology.
[3] H. Shinmoto,et al. Prostate cancer screening: The clinical value of diffusion‐weighted imaging and dynamic MR imaging in combination with T2‐weighted imaging , 2007, Journal of magnetic resonance imaging : JMRI.
[4] B. Issa,et al. In vivo measurement of the apparent diffusion coefficient in normal and malignant prostatic tissues using echo‐planar imaging , 2002, Journal of magnetic resonance imaging : JMRI.
[5] Byung Kwan Park,et al. Value of Diffusion-Weighted Imaging for the Prediction of Prostate Cancer Location at 3T Using a Phased-Array Coil: Preliminary Results , 2007, Investigative radiology.
[6] Kazuro Sugimura,et al. Prostate cancer detection with 3 T MRI: Comparison of diffusion‐weighted imaging and dynamic contrast‐enhanced MRI in combination with T2‐weighted imaging , 2010, Journal of magnetic resonance imaging : JMRI.
[7] N A Obuchowski,et al. Nonparametric analysis of clustered ROC curve data. , 1997, Biometrics.
[8] B. K. Park,et al. Diffusion-Weighted Imaging of the Prostate at 3 T for Differentiation of Malignant and Benign Tissue in Transition and Peripheral Zones: Preliminary Results , 2007, Journal of computer assisted tomography.
[9] Deanna L Langer,et al. Intermixed normal tissue within prostate cancer: effect on MR imaging measurements of apparent diffusion coefficient and T2--sparse versus dense cancers. , 2008, Radiology.
[10] Peter L Choyke,et al. Imaging prostate cancer: a multidisciplinary perspective. , 2007, Radiology.
[11] Fernando J. Kim,et al. Combined T 2-weighted and diffusion-weighted MRI for localization of prostate cancer , 2007 .
[12] 佐藤 千峰,et al. Differentiation of noncancerous tissue and cancer lesions by apparent diffusion coefficient values in transition and peripheral zones of the prostate , 2006 .
[13] S. Piantadosi,et al. Correlation of prostate needle biopsy and radical prostatectomy Gleason grade in academic and community settings. , 1997, The American journal of surgical pathology.
[14] N M deSouza,et al. Diffusion-weighted magnetic resonance imaging: a potential non-invasive marker of tumour aggressiveness in localized prostate cancer. , 2008, Clinical radiology.
[15] Baris Turkbey,et al. Imaging localized prostate cancer: current approaches and new developments. , 2009, AJR. American journal of roentgenology.
[16] N. Obuchowski,et al. Bias, underestimation of risk, and loss of statistical power in patient-level analyses of lesion detection , 2010, European Radiology.
[17] A. Feinstein. Invidious comparisons and unmet clinical challenges. , 1992, The American journal of medicine.
[18] J Kurhanewicz,et al. Prostate cancer: prediction of extracapsular extension with endorectal MR imaging and three-dimensional proton MR spectroscopic imaging. , 1999, Radiology.
[19] S. Okuda,et al. Prostate cancer screening : The clinical value of diffusion-weighted imaging and dynamic MR imaging , 2005 .
[20] Masoom A Haider,et al. Combined T2-weighted and diffusion-weighted MRI for localization of prostate cancer. , 2007, AJR. American journal of roentgenology.
[21] Amita Shukla-Dave,et al. The role of MRI and MRSI in diagnosis, treatment selection, and post-treatment follow-up for prostate cancer. , 2009, Clinical advances in hematology & oncology : H&O.
[22] L. Turnbull,et al. Diffusion‐weighted imaging of normal and malignant prostate tissue at 3.0T , 2006, Journal of magnetic resonance imaging : JMRI.
[23] P. Carroll,et al. Multiparametric magnetic resonance imaging in prostate cancer: present and future , 2008, Current opinion in urology.
[24] Oguz Akin,et al. Multimodality magnetic resonance imaging of prostate cancer. , 2010, Journal of endourology.
[25] W. Fair,et al. Correlation between Gleason score of needle biopsy and radical prostatectomy specimen: accuracy and clinical implications. , 1997, The Journal of urology.
[26] Kyung Ah Kim,et al. Prostate cancer: apparent diffusion coefficient map with T2-weighted images for detection--a multireader study. , 2009, Radiology.
[27] L. Turnbull,et al. Diffusion Imaging of the Prostate at 3.0 Tesla , 2006, Investigative radiology.
[28] Jacob Cohen,et al. Weighted kappa: Nominal scale agreement provision for scaled disagreement or partial credit. , 1968 .
[29] M. Kattan,et al. Correlation of proton MR spectroscopic imaging with gleason score based on step-section pathologic analysis after radical prostatectomy. , 2005, Radiology.
[30] K. Hosseinzadeh,et al. Endorectal diffusion‐weighted imaging in prostate cancer to differentiate malignant and benign peripheral zone tissue , 2004, Journal of magnetic resonance imaging : JMRI.
[31] K Kuppusamy,et al. High-b-value diffusion-weighted MR imaging of adult brain: image contrast and apparent diffusion coefficient map features. , 2000, AJNR. American journal of neuroradiology.
[32] M. Recio. Diffusion-Weighted MRI at 3 T for the Evaluation of Prostate Cancer , 2013 .
[33] N. D. de Souza,et al. Diffusion‐weighted imaging of the prostate and rectal wall: comparison of biexponential and monoexponential modelled diffusion and associated perfusion coefficients , 2009, NMR in biomedicine.
[34] Oguz Akin,et al. Imaging of prostate cancer. , 2002, Radiologic clinics of North America.
[35] H. Hricak,et al. Imaging of prostate cancer. , 2007, Radiologic clinics of North America.
[36] Takeo Ishigaki,et al. Prostate cancer detection with 3-T MRI: comparison of diffusion-weighted and T2-weighted imaging. , 2007, European journal of radiology.
[37] J Alfred Witjes,et al. Staging prostate cancer with dynamic contrast-enhanced endorectal MR imaging prior to radical prostatectomy: experienced versus less experienced readers. , 2005, Radiology.
[38] J. Machan,et al. Diffusion-weighted MRI of peripheral zone prostate cancer: comparison of tumor apparent diffusion coefficient with Gleason score and percentage of tumor on core biopsy. , 2010, AJR. American journal of roentgenology.
[39] J. R. Landis,et al. The measurement of observer agreement for categorical data. , 1977, Biometrics.
[40] M. Pepe,et al. Comparisons of Predictive Values of Binary Medical Diagnostic Tests for Paired Designs , 2000, Biometrics.
[41] William Wells,et al. Detection of prostate cancer by integration of line-scan diffusion, T2-mapping and T2-weighted magnetic resonance imaging; a multichannel statistical classifier. , 2003, Medical physics.
[42] Katsuyoshi Ito,et al. Apparent diffusion coefficient values in peripheral and transition zones of the prostate: Comparison between normal and malignant prostatic tissues and correlation with histologic grade , 2008, Journal of magnetic resonance imaging : JMRI.